Influenza virus surveillance by the Instituto Adolfo Lutz, influenza season 2014: antiviral resistance.
作者信息
Santos Katia Corrêa de Oliveira, Silva Daniela Bernardes Borges da, Benega Margarete Aparecida, Paulino Renato de Sousa, Silva Elian Reis e, Pereira Dejanira dos Santos, Mussi Aparecida Duarte Hg, Silva Valéria Cristina da, V Gubareva Larissa, Paiva Terezinha Maria de
机构信息
Laboratory of Respiratory Viruses NIC/WHO, Instituto Adolfo Lutz, São Paulo, SP, Brazil.
Central Laboratory of Public Health of the Mato Grosso State, Cuiabá, Brazil.
出版信息
Rev Inst Med Trop Sao Paulo. 2015 Jan-Feb;57(1):92. doi: 10.1590/S0036-46652015000100016.
Abstract
摘要
相似文献
1
Influenza virus surveillance by the Instituto Adolfo Lutz, influenza season 2014: antiviral resistance.
Rev Inst Med Trop Sao Paulo. 2015 Jan-Feb;57(1):92. doi: 10.1590/S0036-46652015000100016.
2
Global monitoring of antiviral resistance in currently circulating human influenza viruses, November 2011.
Wkly Epidemiol Rec. 2011 Nov 4;86(45):497-501.
3
Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons.
Wkly Epidemiol Rec. 2007 Apr 27;82(17):149-50.
4
Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.
Clin Infect Dis. 2009 Apr 1;48(7):996-7. doi: 10.1086/597360.
5
Update: influenza activity - United States, September 28, 2008--January 31, 2009.
MMWR Morb Mortal Wkly Rep. 2009 Feb 13;58(5):115-9.
6
Update: influenza activity --- United States, October 3-December 11, 2010.
MMWR Morb Mortal Wkly Rep. 2010 Dec 24;59(50):1651-5.
7
Recommended viruses of influenza vaccines for use in the 2011 influenza season (southern hemisphere).
Wkly Epidemiol Rec. 2010 Oct 8;85(41):402-12.
8
Influenza in Canada: 2005-2006 season.
Can Commun Dis Rep. 2007 Feb 1;33(3):21-41.
9
Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
Antiviral Res. 2013 Sep;99(3):261-9. doi: 10.1016/j.antiviral.2013.06.003. Epub 2013 Jun 17.
10
Update: Influenza Activity - United States.
MMWR Morb Mortal Wkly Rep. 2015 Dec 11;64(48):1342-8. doi: 10.15585/mmwr.mm6448a4.
本文引用的文献
1
Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses.
PLoS Pathog. 2014 Apr 3;10(4):e1004065. doi: 10.1371/journal.ppat.1004065. eCollection 2014 Apr.
2
Detection of oseltamivir-resistant pandemic influenza A(H1N1)pdm2009 in Brazil: can community transmission be ruled out?
PLoS One. 2013 Nov 11;8(11):e80081. doi: 10.1371/journal.pone.0080081. eCollection 2013.
3
Oseltamivir-resistant influenza A(H1N1)pdm09 virus in southern Brazil.
Mem Inst Oswaldo Cruz. 2013 May;108(3):392-4. doi: 10.1590/S0074-02762013000300021.
4
Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors.
Influenza Other Respir Viruses. 2013 Jan;7 Suppl 1(Suppl 1):44-9. doi: 10.1111/irv.12051.
5
Influenza genome analysis using pyrosequencing method: current applications for a moving target.
Expert Rev Mol Diagn. 2009 Jul;9(5):493-509. doi: 10.1586/erm.09.21.
6
Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.
Antimicrob Agents Chemother. 2008 Sep;52(9):3284-92. doi: 10.1128/AAC.00555-08. Epub 2008 Jul 14.
Zotero 插件